Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:hedge_fund
|
| gptkbp:category |
equity ETF
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:currency |
gptkb:USD
|
| gptkbp:CUSIP |
00214Q302
|
| gptkbp:dividendPaying |
low
|
| gptkbp:expenseRatio |
0.75%
|
| gptkbp:focusesOn |
gptkb:biotechnology
genomics healthcare innovation |
| gptkbp:heldBy |
gptkb:Twist_Bioscience
gptkb:Pacific_Biosciences gptkb:CRISPR_Therapeutics gptkb:Exact_Sciences gptkb:Teladoc_Health |
| https://www.w3.org/2000/01/rdf-schema#label |
ARK Genomic Revolution ETF
|
| gptkbp:ISIN |
US00214Q3020
|
| gptkbp:managedBy |
gptkb:ARK_Invest
|
| gptkbp:portfolioCompany |
gptkb:Catherine_Wood
|
| gptkbp:region |
global
|
| gptkbp:startYear |
2014-10-31
|
| gptkbp:stockExchange |
gptkb:NYSE_Arca
|
| gptkbp:stockSymbol |
gptkb:ARKG
|
| gptkbp:strategy |
actively managed
|
| gptkbp:website |
https://ark-funds.com/arkg/
|
| gptkbp:bfsParent |
gptkb:ARK_Invest
|
| gptkbp:bfsLayer |
7
|